Item Infomation
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marius, Trøseid | - |
| dc.contributor.author | José R., Arribas | - |
| dc.contributor.author | Lambert, Assoumou | - |
| dc.date.accessioned | 2023-03-29T08:40:50Z | - |
| dc.date.available | 2023-03-29T08:40:50Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s13054-022-04205-8 | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 | - |
| dc.description | CC BY | vi |
| dc.description.abstract | Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | Bari-SolidAct | vi |
| dc.subject | placebo-controlled phase 3 trial | vi |
| dc.title | Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial | vi |
| dc.type | Book | vi |
| Appears in Collections | ||
| OER- Y học- Điều dưỡng | ||
Files in This Item:
